Blog

There’s a perception that because there isn’t a cure for PD, that means there’s no treatment, no way to improve symptoms, no way to improve quality of life. This is absolutely WRONG – there’s always more we can do!

Alzheimer’s disease is a neurodegenerative condition that affects thinking, behavior and social skills. Dr. Verna Porter, Director of the Dementia, Alzheimer’s Disease and Neurocognitive Disorders Program at Pacific Brain Health Center, talked about some everyday questions that people have with regard to this disease. 1....

The Think Neuro podcast from Pacific Neuroscience Institute takes you into the clinic, operating room and laboratory with doctors and surgeons who are tackling the most challenging brain diseases and disorders. Host: Anthony Effinger Subscribe: Google Podcasts | Apple Podcasts | Spotify | SimplecastWatch: YouTube Episode 9: Show Notes Addiction and depression are...

A new self-administered drug for the treatment of Multiple Sclerosis has been approved by the US Food and Drug Administration (FDA). In a clinical trial, it outperformed an existing oral drug, with respect to decreasing relapses and new areas of nerve damage seen on MRI....

As physicians, we understand the tremendous value of cognitive, physical, and social activity in optimizing and preserving our abilities as we age. At first glance, it is easy to see COVID as an obstacle. However, there are many ways we can emerge from this period sharper, stronger and more resilient.

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Drug shows encouraging signs for patients of less common type of dementia. Pacific Neuroscience Institute located at Providence Saint John’s Health Center among sites for clinical trial.

Ever heard of a disease called Trigeminal Neuralgia? It’s called the “Suicide Disease” because it causes unbearable pain in the face and temples. It’s often triggered by everyday things like brushing teeth, shaving, or putting on makeup.

Jack Verschleiser, a 2017 UCLA graduate who now oversees the university’s ZBT fraternity organization, was struck that two current members had personal experience with cancer. David Phillips, who graduated in June of this year successfully battled Hodgkin’s lymphoma for six months of his junior year....

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...